Genetic testing rates for ovarian cancer low across Ontario Less than seven per cent of Ontario women with the most common type of ovarian cancer were seen for genetics consultation within two years of diagnosis, despite its high potential for life-saving benefits, a...
A new genetic testing method developed at Western University called LipidSeq can identify a genetic basis for high-cholesterol in almost 70 per cent of a targeted patient population. Using next-generation sequencing (NGS) technology, researchers were able to pinpoint...
